Patient Engagement in Drug Development

Monday, March 16, 2015

Speaking at the NHC's 2015 Voluntary Health Leadership Conference, Anton Hoos, MD, Head of Medical R&D Europe at Amgen, describes his company's vision of successful patient engagement in the development of new treatments and cures.